September 18th, 2014
Do Hemodynamic Endpoints Have Value in Patients Treated for Pulmonary Arterial Hypertension?
Corey E Ventetuolo, MD, MS
Corey E. Ventetuolo discusses her research group’s study of hemodynamic endpoints in clinical trials of patients with pulmonary arterial hypertension.
NEJM Journal Watch — Recent Cardiology Articles- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?
- Are Angiographically-Derived Coronary Physiology Measurements Ready for Use in the Cath Lab?
- A Randomized Trial of Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation
- An Early Look at a Novel Intranasal Loop Diuretic